2025 annual financial data
OKYO Pharma 2025 Operating margin
OKYO Pharma 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -7,188,875 USD and net income was -4,706,292 USD.
Operating cash flow was -1,810,931 USD.
Get free OKYO Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,188,875 USD
- Net income
- -4,706,292 USD
- Operating cash flow
- -1,810,931 USD